Success Metrics

Completion Rate
0%(0/2)
Active Trials
1(25%)
Terminated
2(50%)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Terminated(3)

Detailed Status

Terminated2
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (50.0%)
N/A1 (50.0%)

Trials by Status

terminated250%
withdrawn125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
withdrawn

Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients

NCT05579587
recruiting

Observational Registry of Transoral Incisionless Fundoplication (TIF) for Gastroesophageal Reflux Disease (GERD)

NCT05066594
terminatednot_applicable

Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study

NCT01327963
terminatedphase_3

Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment

NCT00857597

Clinical Trials (4)

Showing 4 of 4 trials
NCT05579587

Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients

Withdrawn
NCT05066594

Observational Registry of Transoral Incisionless Fundoplication (TIF) for Gastroesophageal Reflux Disease (GERD)

Recruiting
NCT01327963Not Applicable

Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study

Terminated
NCT00857597Phase 3

Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4